Fidelity Investments’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,836,739
| Closed | -$39.2M | – | 5710 |
|
|
2024
Q1 | $39.2M | Sell |
1,836,739
-3,476,555
| -65% | -$41.6M | ﹤0.01% | 1408 |
|
|
2023
Q4 | $51.1M | Buy |
5,313,294
+1,135,446
| +27% | +$5.52M | ﹤0.01% | 1285 |
|
|
2023
Q3 | $10.9M | Sell |
4,177,848
-503,609
| -11% | -$1.61M | ﹤0.01% | 1804 |
|
|
2023
Q2 | $21.9M | Hold |
4,681,457
| – | – | ﹤0.01% | 1603 |
|
|
2023
Q1 | $17.6M | Buy |
4,681,457
+1,989,403
| +74% | +$7.83M | ﹤0.01% | 1667 |
|
|
2022
Q4 | $8.48M | Sell |
2,692,054
-354,759
| -12% | -$883K | ﹤0.01% | 1957 |
|
|
2022
Q3 | $9.17M | Sell |
3,046,813
-203,867
| -6% | -$509K | ﹤0.01% | 1928 |
|
|
2022
Q2 | $8.09M | Sell |
3,250,680
-152
| -0% | -$699 | ﹤0.01% | 2067 |
|
|
2022
Q1 | $25.3M | Buy |
3,250,832
+20,866
| +0.6% | +$151K | ﹤0.01% | 1683 |
|
|
2021
Q4 | $13.5M | Buy |
3,229,966
+3,495
| +0.1% | +$21.8K | ﹤0.01% | 1995 |
|
|
2021
Q3 | $25.6M | Buy |
3,226,471
+42,262
| +1% | +$356K | ﹤0.01% | 1724 |
|
|
2021
Q2 | $25.7M | Buy |
3,184,209
+45,821
| +1% | +$394K | ﹤0.01% | 1734 |
|
|
2021
Q1 | $33.6M | Buy |
3,138,388
+8,954
| +0.3% | +$105K | ﹤0.01% | 1565 |
|
|
2020
Q4 | $36.8M | Buy |
3,129,434
+4,631
| +0.1% | +$58.2K | ﹤0.01% | 1451 |
|
|
2020
Q3 | $37.6M | Buy |
3,124,803
+85,805
| +3% | +$1.17M | ﹤0.01% | 1305 |
|
|
2020
Q2 | $53.1M | Buy |
+3,038,998
| New | +$52.9M | 0.01% | 1134 |
|
Fidelity Investments's FUSN Position: Q2 2024 in Review
Fidelity Investments sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 1,836,739 shares — an estimated $39.2M sold.
Fidelity Investments first reported a position in FUSN in Q2 2020 and held it in 16 quarters. The position peaked at $53.1M in Q2 2020. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.
- Fidelity Investments reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
- Fidelity Investments sold 1,836,739 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $39.2M.
- Fidelity Investments first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 16 quarters.
- Fidelity Investments's Fusion Pharmaceuticals Inc. Common Shares position peaked at $53.1M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.
Based on Fidelity Investments's 13F filing for Q2 2024, filed 13 Aug 2024.